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Abstract
Introduction: Chromosomal aberrations of chromosome 16 are uncommon and submicroscopic deletions have
rarely been reported. At present, a cytogenetic or molecular abnormality can only be detected in 55% of
Rubinstein-Taybi syndrome patients, leaving the diagnosis in 45% of patients to rest on clinical features only.
Interestingly, this microdeletion of 16 p13.3 was found in a young child with an unexplained syndromic condition
due to an indistinct etiological diagnosis. To the best of our knowledge, no evidence of a microdeletion of 16
p13.3 with contiguous gene deletion, comprising cyclic adenosine monophosphate-response element-binding
protein and tumor necrosis factor receptor-associated protein 1 genes, has been described in typical Rubinstein-
Taybi syndrome.
Case presentation: We present the case of a three-year-old Malaysian Chinese girl with a de novo microdeletion
on the short arm of chromosome 16, identified by oligonucleotide array-based comparative genomic hybridization.
Our patient showed mild to moderate global developmental delay, facial dysmorphism, bilateral broad thumbs and
great toes, a moderate size atrial septal defect, hypotonia and feeding difficulties. A routine chromosome analysis
on 20 metaphase cells showed a normal 46, XX karyotype. Further investigation by high resolution array-based
comparative genomic hybridization revealed a 120 kb microdeletion on chromosomal band 16 p13.3.
Conclusion: A mutation or abnormality in the cyclic adenosine monophosphate-response element-binding protein
has previously been determined as a cause of Rubinstein-Taybi syndrome. However, microdeletion of 16 p13.3
comprising cyclic adenosine monophosphate-response element-binding protein and tumor necrosis factor
receptor-associated protein 1 genes is a rare scenario in the pathogenesis of Rubinstein-Taybi syndrome.
Additionally, due to insufficient coverage of the human genome by conventional techniques, clinically significant
genomic imbalances may be undetected in unexplained syndromic conditions of young children. This case report
demonstrates the ability of array-based comparative genomic hybridization to offer a genome-wide analysis at high
resolution and provide information directly linked to the physical and genetic maps of the human genome. This
will contribute to more accurate genetic counseling and provide further insight into the syndrome.
Introduction
Rubinstein-Taybi syndrome (RSTS) is a well delineated
multiple congenital anomaly syndrome characterized by
mental retardation, broad thumbs and toes, short stature
and specific facial features [1]. The syndrome is, at least
in part, caused by a microdeletion at chromosome 16
p13.3 or by mutations in the gene for the cyclic adeno-
sine monophosphate-response element-binding protein
(Crebbp), which is located at 16 p13.3 [2]. The occur-
rence is generally sporadic and birth prevalence is one
in 100, 000 to 125, 000 [2]. About 55% of patients have
cytogenetic or molecular abnormalities in the Crebbp or
E1A binding protein p300 (Ep300) gene, leaving the
diagnosis in 45% of patients to rest on clinical features
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cal presentation and the limitation of routine chromoso-
mal analysis techniques, definitive diagnosis in younger
children is difficult.
Conventional cytogenetic analysis of patients with syn-
dromic features has largely reported findings of a nor-
mal karyotype. This necessitates the adoption of a more
sensitive method to detect the occurrence of any submi-
croscopic chromosomal aberration. Microarray-based
comparative genomic hybridization (array-CGH) is a
high-throughput technique that offers rapid genome-
wide analysis at high resolution. Array-CGH is designed
to detect not only genome-wide chromosomal and seg-
mental deoxyribonucleic acid (DNA) copy number
changes, but also map and measure the regions of
amplification, which may be associated with a wide
range of diseases, from developmental disorders to can-
cer. The use of current array-CGH technology enables
the detection of submicroscopic chromosomal aberra-
tions at multiple loci and localization of disease gene
regions for subsequent candidate gene identification.
Case presentation
Our patient was a three-year-old Malaysian Chinese girl.
She was the second of two children. Her parents were
healthy and non-consanguineous. There was no signifi-
cant family history. She was delivered at term via an
elective lower segment Cesarean section with a birth
weight of 2.63 kg. A pelvic cyst was detected during the
antenatal period, but this had resolved spontaneously
when a repeat ultrasound was done at six weeks of age.
She was noted to have inspiratory stridor and a diagno-
sis of laryngomalacia was made at 10 weeks of age. She
showed a failure to thrive with slow feeding. Her growth
parameters of weight, length and head circumference
were below the third percentiles. She was given nasogas-
tric feeding. A barium swallow showed no abnormalities.
Her weight gradually improved when a percutaneous
gastroenterostomy tube was inserted. A physical exami-
nation at one year of age showed inspiratory stridor and
dysmorphic features, such as a prominent nasal bridge,
hypertelorism, down-slanting palpebral fissures, a small
mouth, micrognathia, low set ears, sparse hair and bilat-
eral broad thumbs and great toes (Figure 1). There was
a soft systolic murmur heard on auscultation of the left
sternal edge. She had generalized hypotonia but no
other neurological deficits. She had mild to moderate
global developmental delay, w a so n l ya b l et os c r i b b l e ,
climb steps slowly and hold on to the rails, had no
meaningful word in her speech but was able to obey
simple commands and communicate with sign language.
Investigations showed that she had a normal full blood
count and metabolic studies, a normal karyotype and
normal results for a DNA methylation study for Prader-
Willi syndrome. An echocardiogram showed a moderate
size atrial septal defect. She had refractive errors and
failed a distraction test. A peripheral blood sample was
sent for array-CGH analysis at the age of one year and
seven months.
Cytogenetic analyses of our patient and her healthy
parents were performed by G-banding techniques at 550
bands of resolution on metaphase chromosomes
obtained by standard procedures from peripheral blood
lymphocytes. Molecular karyotyping was performed
using commercially available high resolution 244K 60-
mer oligonucleotide microarray slide (Human Genome
CGH Microarray 244A Kit, Agilent Technologies, Santa
Clara, CA, USA) according to the manufacturer’s proto-
col. This platform allows a genome-wide survey and
molecular profiling of genomic aberrations with an aver-
age resolution of about 10 kb.
Cytogenetic analysis of our patient and her parents
showed that they had normal karyotypes. Array-CGH
analysis revealed a microdeletion of chromosome 16
involving band p13.3, with the first clone locating at 3,
651, 083 base pairs on proximal 16 p13.3 and the last
clone locating at 3, 771, 464 base pairs on distal 16 p13.3,
according to the University of California Santa Cruz Gen-
ome Browser on Human March 2006 Assembly
(NCBI36/hg18). The size of the deletion was estimated to
be about 120 kb. The deletion was confirmed by a dye
swap experiment of array-CGH. Multiplex ligation-
dependent probe amplification (MLPA) experiments
were performed to validate the array-CGH finding and to
determine the parental origin of the deletion. The dele-
tion was confirmed to be hemizygous and de novo using
SALSA MLPA kit P313-A1 CREBBP (Microbiology
Research Centre Holland, Amsterdam, The Netherlands).
Discussion
Chromosomal imbalances are known causes of genetic
disorders and often result in a syndromic condition. We
here describe a three-year-old girl with a global develop-
mental delay, dysmorphic features and multiple congeni-
tal anomalies, carrying a 120 kb microdeletion of
chromosome 16 p13.3 detected by array-CGH (Figure
2). The deletion region encompasses two known genes,
for tumor necrosis factor receptor-associated protein 1
(Trap1)a n dCrebbp. It has been demonstrated that the
Trap1 gene is located on chromosome 16 p13.3 between
3, 648, 039 and 3, 707, 599 base pairs while the Crebbp
gene is located on chromosome 16 p13.3 between 3,
716, 570 and 3, 870, 712 base pairs (NCBI36/hg18). The
deleted region in our patient, identified by array-CGH,
was located between 3, 651, 083 and 3, 771, 464 base
pairs. Crebbp was partially deleted while its neighbor
gene, Trap1, was deleted. Further study by MLPA tech-
nique confirmed the deletion within the Crebbp gene to
Mohd Fadly et al. Journal of Medical Case Reports 2012, 6:30
http://www.jmedicalcasereports.com/content/6/1/30
Page 2 of 7be de novo and hemizygous from exons 6 to 31, which
corresponds to between 3, 717, 675 and 3, 772, 856 base
pairs (Figure 3). This MLPA finding is consistent with
the array-CGH result.
In most cases, cytogenetic rearrangements at chromo-
some 16 p13.3 or submicroscopic deletions within 16
p13 were found to be caused by heterozygous molecular
mutations in Crebbp gene [4,5]. The Crebbp gene has
A
B
Figure 1 Clinical features of our patient at the age of three years. Dysmorphic facial features include a prominent nasal bridge,
hypertelorism and down-slanting palpebral fissures. Other features include (a) broad thumbs and fingers and (b) great toes.
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thought to be responsible for the core clinical manifesta-
tions of RSTS in our patient. Crebbp (OMIM: 600140) is
a transcription coactivator and functions as a potent his-
tone acetyltransferase, both of which are essential to
normal development [6]. The Crebbp gene is involved in
different signaling pathways and in certain cellular func-
tions, such as DNA repair, cell growth, differentiation,
apoptosis and tumor suppression. Crebbp gene deletion
[7] or exon deletion [8] are demonstrated in about 8%
to 12% of patients. EP300 (OMIM: 602700) mutations
were also identified as another rare cause of RSTS in 3%
of patients [6]. The Human Gene Mutation Database
(http://www.hgmd.org) holds, at present, 92 different
mutations in the Crebbp gene - 13 missense substitu-
tions, 20 nonsense substitutions, 10 splicing substitu-
tions, 16 small deletions, nine small insertions, two
small indels, 19 gross deletions, one gross insertion and
two complex rearrangements. Previous studies of
patients with RSTS indicated 16 p13.3 deletions of up to
560 kb to 650 kb and including the 5’-a n d3 ’-flanking
regions of the Crebbp gene [4,8,9]. Recently, intragenic
deletions were detected in two RSTS patients using an
exon coverage microarray platform; one in a male
patient resulting from deletion of two exons within the
Crebbp gene and the other in a female patient resulting
from deletion of four exons within the Ep300 gene [10].
Trap1 (OMIM: 606237) is a mitochondrial 90-kilodal-
ton heat shock protein (Hsp90). Hsp90 proteins are
important and highly conserved molecular chaperones
that have key roles in signal transduction, protein fold-
ing, protein degradation and morphologic evolution.
Hsp90 proteins normally associate with other co-chaper-
ones and play important roles in folding newly synthe-
sized proteins or stabilizing and refolding denatured
proteins after stress. The human Hsp90 family includes
17 genes that fall into four classes. Six genes,
Hsp90AA1, Hsp90AA2, Hsp90N, Hsp90AB1, Hsp90B1
and Trap1, were recognized as functional, and the
remaining 11 genes were considered putative pseudo-
genes [11]. Although Trap1 has not been associated
with human disease, the importance of this gene war-
rants attention. In addition, a small subset of RSTS
cases caused by 16 p13.3 microdeletions involving
neighboring genes of Crebbp have recently been sug-
gested to be a true contiguous gene syndrome called
s e v e r eR S T S ,o r1 6p 1 3 . 3d e l e t i o ns y n d r o m e( O M I M :
610543) [12]. Bartsch et al. [12] concluded that
Figure 2 Profile of the microarray analysis showing the deletion region as indicated in the highlighted area. A dye-swap experiment
was performed to maximize the accuracy of detection of the deletion.
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included Crebbp, Trap1 and deoxyribonuclease 1 gene
(DNase1), will result in severe RSTS. A case described
by Wójcik et al. [13] showed an approximate 520.7 kb
microdeletion on 16 p13.3, involving Crebbp, the Adenyl
cyclase 9 and Sarcalumenin genes, in a two-year-old
female with RSTS. Besides most of the typical features
of RSTS, their patient had corpus callosum dysgenesis
and a Chiari type I malformation which required neuro-
surgical decompression. These evidences demonstrated
that microdeletion involving neighboring genes to
Crebbp gene might be responsible for the additional fea-
tures in RSTS. In addition, our finding merits further
interest because no cases of microdeletion 16 p13.3 with
contiguous gene deletion, comprising Crebbp and Trap1
genes, have been described in typical RSTS patients.
It is noteworthy that as our patient grew older her
clinical features became increasingly more consistent
with RSTS. Most of the typical RSTS features as
described by Hennekam [3] were observed. These
Figure 3 The MLPA profile demonstrating a de novo hemizygous deletion of exons 6 to 31 of the CREBBP gene as indicated by the
arrow.
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palpebral fissures, a small mouth, low set ears, bilateral
broad thumbs and great toes and growth retardation.
Congenital heart defects (mainly patent ductus arterio-
sus, ventricular septal defect and atrial septal defect)
were observed in 32% of patients [3]. Although excessive
hair growth (hirsutism) is found in 75% of cases [14],
our patient interestingly had sparse hair, a condition
that has not previously been reported in a typical RSTS
patient. Whether this manifestation is affected by the
abnormality of Trap1 is uncertain. Since our patient
showed most of the typical features of RSTS, we
hypothesized that this region is haplosufficient inasmuch
that the deletion of Trap1 bore no significant complica-
tion to our patient. However, further studies are needed
to clarify the potential role of Trap1 in 16 p13.3
microdeletion.
RSTS can be regarded as a microdeletion syndrome
with a low rate of microdeletions, as only 4% to 25% of
patients with RSTS were found to have the Crebbp dele-
tion on chromosome 16 p13.3 when using fluorescence
in situ hybridization [7]. It is critical that the diagnosis
of an unexplained syndromic condition, especially in
young patients, is confirmed by an advanced laboratory
technique such as array-CGH. An accurate diagnosis
will enable the precision of long-term care and a health
surveillance program for patients with RSTS. This
includes regular monitoring for the emergence of
tumors, immunodeficiencies, early surgical correction of
surgical and orthopedic complications, genetic counsel-
ing for future pregnancy and prenatal diagnosis. In addi-
tion, there is little published literature of longitudinal
studies on this syndrome in the population. The finding
from our patient adds to the increased awareness of
RSTS variability in the population. Our case has been
deposited into the Database of Chromosomal Imbalance
and Phenotype in Humans using Ensembl Resources
(DECIPHER-Patient ID: 254034) [15].
Conclusion
We found this case worthy of reporting as, to date, there
is very little documented evidence of this syndrome
ascertained by microarray analysis. Here, we demon-
strate the superiority of the array-CGH technique over
conventional techniques in the screening and detection
of clinically significant genomic imbalances in the
human genome. Array-CGH is a reliable and powerful
tool in the investigation of rare genetic conditions, espe-
cially cases with a highly variable phenotype and variable
aberrations such as Rubinstein-Taybi syndrome.
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